Latest Incentive Payments News

Aureka Limited is set to become a gold producer after signing a binding agreement to acquire High Grade Holdings, including the Fiddlers Creek underground mine and Wedderburn processing mill in Victoria. The majority scrip, low cash deal valued at $8.9 million unlocks immediate production and processing capacity for Aureka’s Victorian gold projects.

Harvey Norman Holdings reported a 10.9% rise in profit before tax excluding one-off adjustments, driven by international retail growth and a robust property portfolio. The company declared a fully franked 13 cent final dividend, maintaining a strong balance sheet with conservative gearing.

NTAW Holdings reported a 15.7% revenue drop to $445.3 million in FY2026 but improved net losses and operating EBITDA amid a strategic reset. The company divested its South African stake and plans asset sales as it targets modest growth in FY2027.

Peet Limited delivered a record FY26 with net profit after tax soaring 77% to $103.4 million, driven by robust sales and a 39% jump in contracts on hand. The company boosted dividends by 68%, reflecting confidence in its diverse masterplanned communities pipeline.

InvestSMART Group Limited swung to a net loss of $575,633 in FY26, marking a sharp reversal from the prior year’s profit, amid a strategic pivot including a pending $16 million sale of its Intelligent Investor business.

NextEd Group navigated a tough international education market in FY26, boosting underlying EBITDA by 7% to $15.3 million even as revenue fell 6.7%. A $13 million goodwill impairment weighed on net losses, but ongoing cost discipline and vocational course growth underpin a resilient platform.

Orora’s FY26 results reveal a $616.6 million statutory loss driven by a $742.8 million Glass impairment, offset by robust growth in its Cans business and disciplined capital management.

PointsBet’s FY26 nine-month report reflects a transitional period marked by MIXI’s 66.4% takeover, a slight revenue dip to AUD 186.6 million, and a near breakeven normalised EBITDA. Australian revenue softened by 4%, while Canada grew 13% driven by iGaming momentum.

Praemium plans a staged rollout of its new core technology platform this year, following the integration of Technotia Laboratories. The company has restructured its tech team to cut costs and revised incentive payments for two founding Technotia principals transitioning to consulting roles.

Green Cross Health lifted net profit by 28% to NZD 20.4 million in FY26, driven by stronger medical funding and pharmacy revenue growth, while preparing to launch a new Primary Health Organisation.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.